 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Safety and Efficacy Study Using Rexin-G for Sarcoma
|
|
|
|
Phase II, Phase I
|
|
|
|
C07-103
NCT00505713
|
|
| |
Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors
|
|
|
|
Phase II
|
|
|
|
NHLBI-99-H-0064
NCT00003839
|
|
| |
A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide and Cisplatin in Patients With MMT of the Uterus
|
|
|
|
Phase II
|
|
|
|
MMC-03-02-040
NCT00231842
|
|
| |
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
|
|
|
|
Phase II
|
|
|
|
GOG-0087M
GOG-0087M, NCT00379145
|
|
| |
VEGF Trap in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-051
7502, NCI-7502, NCT00390234
|
|
| |
Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
|
|
|
|
Phase II
|
|
|
|
PMH-PHL-062
7713, PHL-062, NCT00478426
|
|
| |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
|
|
|
|
Phase II
|
|
|
|
MSKCC-05122
NCT00445965
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
| |
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally
Recurrent Sarcomas
|
|
|
|
Phase II
|
|
|
|
MSKCC-07054
07-054, PFIZER-MSKCC-07054, NCT00474994
|
|
| |
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
|
|
|
|
Phase II
|
|
|
|
06-063
NCT00476086
|
|
